Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

99 trials with published results (11%)

Research Maturity

573 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

53 terminated out of 905 trials

Success Rate

91.5%

+4.9% vs benchmark

Late-Stage Pipeline

19%

172 trials in Phase 3/4

Results Transparency

17%

99 of 573 completed with results

Key Signals

99 with results92% success53 terminated

Data Visualizations

Phase Distribution

525Total
Not Applicable (217)
Early P 1 (9)
P 1 (51)
P 2 (76)
P 3 (60)
P 4 (112)

Trial Status

Completed573
Unknown144
Recruiting66
Terminated53
Active Not Recruiting27
Withdrawn21

Trial Success Rate

91.5%

Benchmark: 86.6%

Based on 573 completed trials

Clinical Trials (905)

Showing 20 of 20 trials
NCT01143454Recruiting

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

NCT00353782Recruiting

Causes and Natural History of Dyslipidemias

NCT01399385Not ApplicableRecruiting

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT07856199Not ApplicableRecruiting

Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease

NCT07783802Phase 2RecruitingPrimary

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

NCT07448038Phase 2RecruitingPrimary

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

NCT07840950Not ApplicableNot Yet Recruiting

Effects of Rosa Roxburghii Tratt Freeze-Dried Powder on Carotid Atherosclerotic Plaques: A Real-World Study

NCT07837934Phase 2Recruiting

Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes

NCT07839936Phase 2Not Yet RecruitingPrimary

A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular Disease

NCT07613294Phase 3RecruitingPrimary

A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

NCT07521007Phase 2RecruitingPrimary

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

NCT01143480Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT05906797Not ApplicableCompletedPrimary

Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis.

NCT02991703Not ApplicableCompleted

Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children

NCT07800351Phase 3Not Yet Recruiting

Nicorandil in Atherosclerosis Risk in Patients With Rheumatoid Arthritis

NCT06327984Recruiting

Barts Sex-CAD Database - Sex Hormones and Inflammatory Status in Coronary Artery Disease

NCT05821894RecruitingPrimary

Atherosclerotic Plaque Imaging Project (CPIP)

NCT02932176CompletedPrimary

Machine Learning for Handheld Vascular Studies

NCT03636152Phase 2Completed

Management of Cardiovascular Disease in Kidney Disease (MaCK) Study

NCT07625488Enrolling By Invitation

Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)

Scroll to load more

Research Network

Activity Timeline